GLI will be attending HCC-TAG.
The purpose of HCC-TAG is to bring together clinicians and researchers in academia and the pharmaceutical industry for a focused educational update to highlight the most relevant advances and challenges in the diagnosis and therapy of HCC. This single-topic conference will take place over two days in Huntington Beach, CA, providing attendees with an understanding of current and future directions in the HCC treatment landscape as well as prospects and challenges in drug discovery and development for HCC. Nationally and internationally renowned faculty will assist in the development of the educational content and will serve as faculty at the conference.
Visit the Website: https://www.hcc-tag.org